tradmap

DNA Ginkgo Bioworks Holdings, Inc.

$9.16 +7.26%

Healthcare · Biological Products, (No Diagnostic Substances)

Ginkgo Bioworks Holdings, Inc. (DNA) is a healthcare company in the Biological Products, (No Diagnostic Substances) industry, with a market capitalization of $565 million. Shares last traded at $9.16, 47.7% below their 52-week high. Over the past year the stock is up 7.0%. Net profit margin is -0.2%, below the peer median of 6.3%. Revenue declined 25.1% year over year.

Market Cap
$565M
Shares Out
61.7M
EPS (TTM)
$-17.25
P/E Ratio
P/S Ratio
3.32
P/B Ratio
1.27
Dividend / Share
Dividend Yield
52-Week High
$17.53
52-Week Low
$5.37
Volume
46,878
Avg Vol (3m)
58,597.222

Performance

1W
+14.64%
1M
+24.63%
3M
+32.37%
6M
+11.10%
YTD
+5.29%
1Y
+7.01%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
59.07
SMA (50)
$8.31
SMA (200)
$9.36
Price vs SMA50
+10.23%
Price vs SMA200
-2.16%
ATR (14)
$0.70

Financials

Revenue
$170M
Net Income
$-0M
Gross Margin
Operating Margin
-185.3%
Net Margin
-0.2%
Return on Equity
-0.1%
Return on Assets
-0.0%
Current Ratio
5.15
Debt / Equity
1.33
Revenue Growth (YoY)
-25.1%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

PeriodEPS (diluted)Reported
FY 2025 $-5.64 2026-02-26
Q3 2025 $-4.22 2025-11-06
Q2 2025 $-2.77 2025-08-07
Q1 2025 $-1.68 2025-05-06
FY 2025 $-10.54 2026-02-26
Q3 2025 $-8.58 2025-11-06

Full earnings history →

Biological Products, (No Diagnostic Substances) peers

DNA vs 14 industry peers (Biological Products, (No Diagnostic Substances)), by market cap.

P/S vs peers
3.32 / 5.21 med
-36% discount
Net margin vs peers
-0.2% / 6.3% med
below median
1–14 of 14
AMGNAmgen$182.1B23.624.9621.0%-1.27%
GILDGilead Sciences$153.5B18.045.2128.9%-1.46%
RVMDRevolution Medicines, Inc.$34.6B-30.62+3.14%
BIIBBiogen$29.0B22.442.9313.1%-1.15%
MRNAModerna$25.4B-8.99+3.22%
NBIXNeurocrine Biosciences Inc$15.9B33.245.5616.7%-0.48%
EXELExelixis, Inc.$13.1B16.685.6233.7%-1.04%
KRYSKrystal Biotech, Inc.$10.2B50.0226.3352.6%+1.68%
TECHBio-Techne$9.1B123.617.446.0%+5.36%
HALOHalozyme Therapeutics, Inc.$8.1B25.675.8222.7%-0.03%
IBRXImmunitybio, Inc.$7.7B-21.87+5.01%
RGENRepligen Corp$7.4B152.2710.086.6%-1.20%
KYMRKymera Therapeutics, Inc.$7.4B23.88+0.44%
PCVXVaxcyte, Inc.$7.4B-9688.00+1.57%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.